1

Human Matrix metalloproteinase 3 ELISA
Cat. No.: BA1013
Enzyme Immunoassay for the quantitative determination of Matrix
metalloproteinase 3 (MMP-3) in human serum and plasma.
Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases,
responsible for the integrity of the basement membrane (BM) via
degradation of extracellular matrix and BM components. MMPs arepresented in various types of cells, including cardiomyocytes, cerebral
neurons, hepatocytes, and many others, thus influencing various processes.
MMP-3, also called stromelysin 1, is reported to be found in the cytosol of
dopaminergic cells where its activation under stress conditions contributes
to neuronal degradation.1 In chondrocytes, nuclear MMP-3 is suggested tobe involved in the development of inflammatory arthritic diseases.2 Matrix
metalloproteinase-3 (MMP-3) is implicated in the formation ofatherosclerotic plaques, and the MMP-3 −1612 5A/6A polymorphism is
associated with myocardial infarction (MI) and stable coronary arterydisease (CAD).3Kit Contents
Item
Antibody Coated Microtiter Plate
Biotin-labelled Antibody
Streptavidin-HRP ConjugateMaster Standard (lyophilized)
Quality Control A (human serum, lyophilized)
Quality Control B (human serum, lyophilized)
Dilution Buffer
Wash Buffer 15x conc.
Substrate Solution
STOP Solution
MATERIAL REQUIRED BUT NOT SUPPLIED
1.
2.
3.
4.
5.

PRINCIPLE OF MMP-3 ELISA
The microtiter plate is coated with the antibody specifically binding theMatrix metalloproteinase 3. The human serum or plasma is incubated in theplate with the capture antibody.
The specimen is washed out and the specifically bound protein is incubatedwith biotin-labelled detection antibody. Following another washing step,
Streptavidin-HRP conjugate is added into the well.
Unbound reagent is then washed out. Horseradish peroxidase (HRP) boundin the complex reacts with the chromogenic substrate (TMB) creating theblue colour. The reaction is stopped by addition of STOP solution (H2SO4).
The absorbance values are measured at 450 nm (optionally 450/630 nm)
and are proportional to the concentration of MMP-3 in the specimen. The
concentration of MMP-3 in unknown samples is determined from thecalibration curve which is created by plotting the absorbance values against
the standard concentration values.

Qty.
96 wells
13 mL
13 mL
1 vial1 vial1 vial
15 mL
50 mL
13 mL
13 mL

Glassware and test tubes
Microtiter plate washer
Precision pipettes (various volumes) with tips
Orbital shaker
Microtiter plate reader capable of measuring absorbanceat 450 nm or 450/630 nm with software for data generation

WARNINGS AND PRECAUTIONS
1.
2.
3.
4.
5.
6.
7.

For research use only
For professional laboratory use
The reagents with different lot numbers should not be mixed
To prevent cross sample contamination, use disposable labware
and pipette tips
To protect laboratory stuff, wear protective gloves andprotective clothing
The substrate solution should remain colourless, keep it
protected from light
The test should be performed at standard laboratory conditions(temperature 25oC ± 2oC).

STORAGE CONDITIONS
1.
2.

The kit must be stored at 2 – 8oC.
The opened components can be stored for one week at 2 – 8oC.

PREPARATION OF REAGENTS

Use new pipette tip for pipetting different reagents and samples
to prevent cross-contamination.
All reagents and samples should be allowed to reach thetemperature 25oC ± 2oC.

Preparation of Standards
Reconstitute lyophilized Human MMP-3 Standard in Dilution Buffer, for thevolume information see the Certificate of Analysis. Let it rehydrate for 15min prior to use. The concentration of human MMP-3 in Master Standard is
10 ng/mL.
Prepare set of Standard solution as follows:
Use the Master Standard for serial dilution (as below). Mix each tube
thoroughly before the next transfer. The Dilution Buffer serves as Blank.
Volume of Standard

v_02

Std1

Standard 10 ng/mL (lyophilized)

Dilution
Buffer1000 µL

Concentration

Std2250 µL of Std1250 µL

5 ng/mLStd3250 µL of Std2375 µL

2 ng/mL

Std4

250 µL of Std3

250 µL

1 ng/mL

Std5250 µL of Std4

250 µL

0.5 ng/mL

Std6250 µL of Std5375 µL

0.2 ng/mLBlank-200 µL

0 ng/mL

10 ng/mL

2Preparation of Quality Control A and B
Reconstitute the lyophilized human serum Quality Controls indeionized/distilled water, for the volume information see the Certificate ofAnalysis. Let the QCs rehydrate for 15 min and dilute them 1:15 in Dilution
Buffer, prior to use, see Preparation of samples.

3.

AccuracyDilution linearity
SampleDilution

Measuredconcentration(ng/mL)
16.0
8.0
3.7
1.9
21.1
10.6
5.0
2.2

Expected
concentration(ng/mL)
8.0
4.0
2.0
10.5
5.3
2.6

Yield(%)

Measuredconcentration(ng/mL)
15.8
51.4
31.0
23.7

Expected
concentration(ng/mL)
45.8
30.8
23.3

Yield (%)

Preparation of Wash Buffer 1x
Prepare a working solution of Wash Buffer by adding 50 mL of Wash Buffer
15x conc. to 700 mL of deionized/ distilled water (dH2O). Mix well. Store at
4oC for two weeks or at -20oC for long term storage.

1Preparation of samples

22x4x8x2x4x8x

Human serum or plasma may be used with this assay. For long-term storage
the samples should be frozen at minimum -70oC. Lipemic or haemolytic
samples may cause false results.
Recommended dilution of samples is 1:15, i.e., for singlets 10 µL of sample+ 140 µL of Dilution Buffer, for duplicates 20 µL of samples + 280 µL ofDilution Buffer, respectively.

Spiking Recovery
SampleSpike(ng/ml)

130.0
15.0
7.5

Do not store the diluted samples.
ASSAY PROCEDURE
1.
2.

The standard curve needs to be measured in every test. Most of themicroplate reader can automatically calculate the analyte concentration
using 4-parameter algorithm or alternative functions to fit the standard
points properly. The concentrations need to be multiplied by the dilution
factor, either automatically by reader or manually.

Human MMP-3 Standard Curve
32.5

PERFORMANCE CHARACTERISTICS
Samples used in the tests were diluted 1:15 as recommended and assayed.
The results are multiplied by the dilution factor.
1.

Sensitivity

The limit of detection, defined as a concentration of human MMP-3 giving
absorbance higher than absorbance of blank + 3 standard deviations, isbetter than 0.05 ng/mL of sample.
2.

2
1.5
1
0.5
00.2Precision

Mean (ng/mL)
16.1
21.8

SD
0.4
1.3CV (%)
261

2

5

10

Mean (ng/mL)
20.5
6.0

RESOURCES
1Choi DH, Kim EM, Son HJ, Joh TH, Kim YS, Kim D, Flint Beal M & Hwang O (2008) A novel intracellularrole of matrix metalloproteinase-3 during apoptosis of dopaminergic cells. J Neurochem 106, 405–415.
2Inter-assay (Run – to – run)
Sample120.5

Concentration (ng/mL)

Intra-assay
Sample12112
101101

Typical standard curve

Absorbance (450/630 nm)

Prepare the reagents as described in the previous chapter.
Pipette 100 µL of set of Standards, Quality Controls, diluted
Samples and Dilution Buffer = Blank into each well. Incubate for
1 hour at 25oC ±2oC, shaking at 300 rpm.
3. Wash the wells 3-times with 1x Wash Buffer (350 µL/well). When
finished, tap the plate against the paper towel to remove theliquid completely.
4. Pipette 100 µL of Biotin-labelled Antibody into each well.
Incubate for 1 hour at 25oC ±2oC, shaking at 300 rpm.
5. Wash the wells as described in point 3.
6. Pipette 100 µL of Streptavidin-HRP into each well. Incubate for
30 min at 25oC ±2oC, shaking at 300 rpm.
7. Wash the wells as described in point 3.
8. Pipette 100 µL Substrate solution, incubate for 15 min,at 25oC ±2oC. Avoid exposure to the light during this step.
9. Pipette 100 µL of STOP solution.
10. Read the signal at 450 or 450/630 nm within 15 min.

10093961019484SD
1.20.1CV (%)
62Eguchi T, Kubota S, Kawata K, Mukudai Y, Uehara J, Ohgawara T, Ibaragi S, Sasaki A, Kuboki T &Takigawa M (2008) Novel transcription-factor-like function of human matrix metalloproteinase 3
regulating the CTGF/CCN2 gene. Mol Cell Biol 28, 2391–2413.3 Moolhuijsen LME, Visser JA. AntiMüllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function. J Clin EndocrinolMetab. 2020 Nov 1;105(11):3361–73. doi: 10.1210/clinem/dgaa513. PMID: 32770239; PMCID:PMC7486884.
3

Samnegård A, Silveira A, Lundman P, Boquist S, Odeberg J, Hulthe J, McPheat W, Tornvall P,Bergstrand L, Ericsson CG, Hamsten A, Eriksson P. Serum matrix metalloproteinase-3 concentration

v_02

3

is influenced by MMP-3 -1612 5A/6A promoter genotype and associated with myocardial infarction.
J Intern Med. 2005 Nov;258(5):411-9. doi: 10.1111/j.1365-2796.2005.01561.x. PMID: 16238676.

v_02